Affiliation:
1. Department of Hematology-Oncology, Istituto Clinico Humanitas, Rozzano, Italy
Abstract
Learning Objectives
After completing this course, the reader will be able to: Select a patient candidate for a tyrosine kinase inhibitor therapy.Describe the mechanism of action of gefitinib and erlotinib.Discuss the role of clinical and biological factors as determinants for sensitivity or resistance to tyrosine kinase inhibitors in lung cancer.
CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com
Publisher
Oxford University Press (OUP)
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献